Market capitalization | $94.02m |
Enterprise Value | $29.51m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.53 |
P/S ratio (TTM) P/S ratio | 1.70 |
P/B ratio (TTM) P/B ratio | 0.72 |
Revenue growth (TTM) Revenue growth | 16.08% |
Revenue (TTM) Revenue | $55.16m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
5 Analysts have issued a 908 Devices Inc forecast:
5 Analysts have issued a 908 Devices Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 55 55 |
16%
16%
|
|
Gross Profit | 26 26 |
18%
18%
|
|
EBITDA | -28 -28 |
29%
29%
|
EBIT (Operating Income) EBIT | -32 -32 |
25%
25%
|
Net Profit | -60 -60 |
55%
55%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.
Head office | United States |
CEO | Kevin Knopp |
Employees | 230 |
Founded | 2012 |
Website | www.908devices.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.